The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance
Open accessAbstract
Pseudomonas aeruginosa is an opportunistic pathogen causing nosocomial infections in severely ill and immunocompromised patients. Ubiquitously disseminated in the environment, especially in hospitals, it has become a major threat to human health due to the constant emergence of drug-resistant strains. Multiple resistance mechanisms are exploited by P. aeruginosa, which usually result in chronic infections difficult to eradicate. Diverse virulence factors responsible for bacterial adhesion and colonization, host immune suppression, and immune escape, play important roles in the pathogenic process of P. aeruginosa. As such, antivirulence treatment that aims at reducing virulence while sparing the bacterium for its eventual elimination by the immune system, or combination therapies, has significant advantages over traditional antibiotic therapy, as the former imposes minimal selective pressure on P. aeruginosa, thus less likely to induce drug resistance. In this review, we will discuss the virulence factors of P. aeruginosa, their pathogenic roles, and recent advances in antivirulence drug discovery for the treatment of P. aeruginosa infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control
Rutherford, S. T., & Bassler, B. L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012427 · Cited by 2,129
Lewis, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.999-1007.2001 · Cited by 1,980
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422
Anti-virulence strategies to combat bacteria-mediated disease
Rasko, D. A., & Sperandio, V. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3013 · Cited by 1,373
Pseudomonas aeruginosa : new insights into pathogenesis and host defenses
Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295 · cited 2×
“…toxins that cause tissue damage, and quorum-sensing and biofilm that confer bacterial communication and drug resistance (Hauser, 2009; Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 Veesenmeyer et al., 2009; Poole, 2011; Gellatly and Hancock, 2013; Newman et al., 2017).”
BackgroundLeVine, A. M., Kurak, K. E., Wright, J. R., Watford, W. T., Bruno, M. D., Ross, G. F., Whitsett, J. A., & Korfhagen, T. R. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.2.3303 · Cited by 1,273
A Virulence Locus of Pseudomonas aeruginosa Encodes a Protein Secretion Apparatus
Mougous, J. D., Cuff, M. E., Raunser, S., Shen, A., Zhou, M., Gifford, C. A., Goodman, A. L., Joachimiak, G., Ordoñez, C. L., Lory, S., et al. (2006) · Science · doi:10.1126/science.1128393 · Cited by 1,103
WHO PUBLISHES LIST OF BACTERIA FOR WHICH NEW ANTIBIOTICS ARE URGENTLY NEEDED
City, P. S. M. M. (2017) · Cited by 1,071
The type III secretion injectisome
Cornelis, G. R. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1526 · Cited by 1,067
LPS, TLR4 and infectious disease diversity
Miller, S. I., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 998
Active Starvation Responses Mediate Antibiotic Tolerance in Biofilms and Nutrient-Limited Bacteria
Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., McKay, G., Siehnel, R., Schafhauser, J., Wang, Y., et al. (2011) · Science · doi:10.1126/science.1211037 · Cited by 978
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles
Ellis, T. N., & Kuehn, M. J. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-09 · Cited by 955
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
A Type VI Secretion System of Pseudomonas aeruginosa Targets a Toxin to Bacteria
Hood, R. D., Singh, P., Hsu, F., Güvener, T., Carl, M. A., Trinidad, R. R. S., Silverman, J. M., Ohlson, B. B., Hicks, K. G., Plemel, R. L., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2009.12.007 · Cited by 932
Pseudomonas aeruginosa Biofilms
Thi, M. T. T., Wibowo, D., & Rehm, B. H. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228671 · Cited by 911
Biofilm infections, their resilience to therapy and innovative treatment strategies
Römling, U., & Balsalobre, C. (2012) · Journal of Internal Medicine · doi:10.1111/joim.12004 · Cited by 865
Type V Protein Secretion Pathway: the Autotransporter Story
Henderson, I. R., Navarro-Garcia, F., Desvaux, M., Fernandez, R. C., & Ala'Aldeen, D. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.4.692-744.2004 · Cited by 841
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
The biology and future prospects of antivirulence therapies
Cegelski, L., Marshall, G. R., Eldridge, G. R., & Hultgren, S. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1818 · Cited by 788 · cited 2×
“…sensing (QS) is a bacterial cell-to-cell communication system, in which the bacteria recognize the self-secreted small signal molecules called autoinducers, coordinate expression of multiple genes involved in bacterial community behaviors, virulence, and biofilm formation (Cegelski et al., 2008).”
BackgroundInvolvement of Nitric Oxide in Biofilm Dispersal of Pseudomonas aeruginosa
Barraud, N., Hassett, D. J., Hwang, S.-H., Rice, S. A., Kjelleberg, S., & Webb, J. S. (2006) · Journal of Bacteriology · doi:10.1128/jb.00779-06 · Cited by 783
A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
O’Loughlin, C. T., Miller, L. C., Siryaporn, A., Drescher, K., Semmelhack, M. F., & Bassler, B. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316981110 · Cited by 744
Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster
Triantafilou, M., & Triantafilou, K. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02233-0 · Cited by 730
Type VI secretion delivers bacteriolytic effectors to target cells
Russell, A. B., Hood, R. D., Bui, N. K., LeRoux, M., Vollmer, W., & Mougous, J. D. (2011) · Nature · doi:10.1038/nature10244 · Cited by 710
The role of pyocyanin in Pseudomonas aeruginosa infection
Lau, G. W., Hassett, D. J., Ran, H., & Kong, F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.10.002 · Cited by 688
Pseudomonas aeruginosa Twitching Motility: Type IV Pili in Action
Burrows, L. L. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150055 · Cited by 669
Type III Secretion Systems and Disease
Coburn, B., Sekirov, I., & Finlay, B. B. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-07 · Cited by 644
Colvin, K. M., Irie, Y., Tart, C. S., Urbano, R., Whitney, J. C., Ryder, C., Howell, P. L., Wozniak, D. J., & Parsek, M. R. (2012) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02657.x · Cited by 612
Pseudomonas biofilm matrix composition and niche biology
Mann, E. E., & Wozniak, D. J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00322.x · Cited by 606
A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence
Balasubramanian, D., Schneper, L., Kumari, H., & Mathee, K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1039 · Cited by 591
Siderophore-mediated signaling regulates virulence factor production in Pseudomonas aeruginosa
Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., & Vasil, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092016999 · Cited by 584
Biosynthesis of the Pseudomonas aeruginosa Extracellular Polysaccharides, Alginate, Pel, and Psl
Franklin, M. J., Nivens, D. E., Weadge, J. T., & Howell, P. L. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00167 · Cited by 576
Tit-for-Tat: Type VI Secretion System Counterattack during Bacterial Cell-Cell Interactions
Basler, M., Ho, B. T., & Mekalanos, J. J. (2013) · Cell · doi:10.1016/j.cell.2013.01.042 · Cited by 556
Type IV pili: dynamics, biophysics and functional consequences
Craig, L., Forest, K. T., & Maier, B. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0195-4 · Cited by 506
ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system
Yahr, T. L., Vallis, A. J., Hancock, M. K., Barbieri, J. T., & Frank, D. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13899 · Cited by 464
Diggle, S. P., & Whiteley, M. (2020) · Microbiology · doi:10.1099/mic.0.000860 · Cited by 459
Roy‐Burman, A., Savel, R. H., Racine, S., Swanson, B. L., Revadigar, N. S., Fujimoto, J., Sawa, T., Frank, D. W., & Wiener‐Kronish, J. P. (2001) · The Journal of Infectious Diseases · doi:10.1086/320737 · Cited by 455
Wu, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh223 · Cited by 446
Type IV pili mechanochemically regulate virulence factors in Pseudomonas aeruginosa
Persat, A., Inclan, Y. F., Engel, J. N., Stone, H. A., & Gitai, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502025112 · Cited by 424
Iron uptake and metabolism in pseudomonads
Cornelis, P. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2550-2 · Cited by 421
Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosa
Hall, S., McDermott, C., Anoopkumar-Dukie, S., McFarland, A., Forbes, A., Perkins, A., Davey, A., Chess-Williams, R., Kiefel, M., Arora, D., et al. (2016) · Toxins · doi:10.3390/toxins8080236 · Cited by 421
Barken, K. B., Pamp, S. J., Yang, L., Gjermansen, M., Bertrand, J. J., Klausen, M., Givskov, M., Whitchurch, C. B., Engel, J. N., & Tolker‐Nielsen, T. (2008) · Environmental Microbiology · doi:10.1111/j.1462-2920.2008.01658.x · Cited by 418
Nivens, D. E., Ohman, D. E., Williams, J., & Franklin, M. J. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.3.1047-1057.2001 · Cited by 416
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU
Sato, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg290 · Cited by 390
Wilson, R., Sykes, D. A., Watson, D., Rutman, A., Taylor, G. W., & Cole, P. J. (1988) · Infection and Immunity · doi:10.1128/iai.56.9.2515-2517.1988 · Cited by 374 · cited 1×
“Pyocyanin (PCN) is a blue secondary metabolite with redox activity found in sputum from P. aeruginosa infected lungs (Wilson et al., 1988; Lau et al., 2004).”
BackgroundProtein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons
Bleves, S., Viarre, V., Salacha, R., Michel, G. P. F., Filloux, A., & Voulhoux, R. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.08.005 · Cited by 371
Rashid, M. H., Rumbaugh, K., Passador, L., Davies, D. G., Hamood, A. N., Iglewski, B. H., & Kornberg, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170283397 · Cited by 364
Sawa, T., Yahr, T. L., Ohara, M., Kurahashi, K., Gropper, M. A., Wiener-Kronish, J. P., & Frank, D. W. (1999) · Nature Medicine · doi:10.1038/7391 · Cited by 362
Overhage, J., Bains, M., Brazas, M. D., & Hancock, R. E. W. (2008) · Journal of Bacteriology · doi:10.1128/jb.01659-07 · Cited by 358
Whitchurch, C. B., Leech, A. J., Young, M. D., Kennedy, D., Sargent, J. L., Bertrand, J. J., Semmler, A. B. T., Mellick, A. S., Martin, P. R., Alm, R. A., et al. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04026.x · Cited by 346
Taylor, P. K., Yeung, A. T. Y., & Hancock, R. E. W. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.09.003 · Cited by 340
Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria
Feuillet, V., Medjane, S., Mondor, I., Demaria, O., Pagni, P. P., Galán, J. E., Flavell, R. A., & Alexopoulou, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605200103 · Cited by 336
The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa – a review
Hahn, H. P. (1997) · Gene · doi:10.1016/s0378-1119(97)00116-9 · Cited by 334
May, T. B., Shinabarger, D., Maharaj, R., Kato, J., Chu, L., DeVault, J. D., Roychoudhury, S., Zielinski, N. A., Berry, A., & Rothmel, R. K. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.2.191 · Cited by 327
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L. (2020) · Advanced Science · doi:10.1002/advs.201901872 · Cited by 314
Fleitas Martínez, O., Cardoso, M. H., Ribeiro, S. M., & Franco, O. L. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00074 · Cited by 304
Quorum quenching quandary: resistance to antivirulence compounds
Maeda, T., García-Contreras, R., Pu, M., Sheng, L., Garcia, L. R., Tomás, M., & Wood, T. K. (2012) · The ISME Journal · doi:10.1038/ismej.2011.122 · Cited by 300
Pseudomonas aeruginosa biofilms: role of the alginate exopolysaccharide
Boyd, A., & Chakrabarty, A. M. (1995) · Journal of Industrial Microbiology · doi:10.1007/bf01569821 · Cited by 286
Pseudomonas Exotoxin A: optimized by evolution for effective killing
Michalska, M., & Wolf, P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00963 · Cited by 283
A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
DiGiandomenico, A., Keller, A. E., Gao, C., Rainey, G. J., Warrener, P., Camara, M. M., Bonnell, J., Fleming, R., Bezabeh, B., Dimasi, N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009655 · Cited by 277
Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway
Yahr, T. L., Goranson, J., & Frank, D. W. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.01554.x · Cited by 275
Starkey, M., Lepine, F., Maura, D., Bandyopadhaya, A., Lesic, B., He, J., Kitao, T., Righi, V., Milot, S., Tzika, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004321 · Cited by 273
Jiang, F., Waterfield, N. R., Yang, J., Yang, G., & Jin, Q. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.04.010 · Cited by 270
Jacob‐Dubuisson, F., Locht, C., & Antoine, R. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02278.x · Cited by 261
Genomics of pyoverdine-mediated iron uptake in pseudomonads
Ravel, J., & Cornelis, P. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00076-3 · Cited by 255
PIER, G. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.03.012 · Cited by 253
Iron acquisition and its control in Pseudomonas aeruginosa: Many roads lead to Rome
Poole, K. (2003) · Frontiers in Bioscience · doi:10.2741/1051 · Cited by 217
Composition, function, and regulation of T6SS in Pseudomonas aeruginosa
Chen, L., Zou, Y., She, P., & Wu, Y. C. (2015) · Microbiological Research · doi:10.1016/j.micres.2015.01.004 · Cited by 211
The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology
Huszczynski, S. M., Lam, J. S., & Khursigara, C. M. (2019) · Pathogens · doi:10.3390/pathogens9010006 · Cited by 207
Anti-virulence Strategies to Target Bacterial Infections
Mühlen, S., & Dersch, P. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_490 · Cited by 198
Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*
Veesenmeyer, J. L., Hauser, A. R., Lisboa, T., & Rello, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ff137 · Cited by 196
Powell, L. C., Pritchard, M. F., Ferguson, E. L., Powell, K. A., Patel, S. U., Rye, P. D., Sakellakou, S.-M., Buurma, N. J., Brilliant, C. D., Copping, J. M., et al. (2018) · npj Biofilms and Microbiomes · doi:10.1038/s41522-018-0056-3 · Cited by 189
The Type VI Secretion System: A Dynamic System for Bacterial Communication?
Gallique, M., Bouteiller, M., & Mérieau, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01454 · Cited by 178
Pseudomonas aeruginosa Psl Is a Galactose- and Mannose-Rich Exopolysaccharide
Ma, L., Lu, H., Sprinkle, A., Parsek, M. R., & Wozniak, D. J. (2007) · Journal of Bacteriology · doi:10.1128/jb.00620-07 · Cited by 176
A novel type II secretion system in Pseudomonas aeruginosa
Ball, G., Durand, É., Lazdunski, A., & Filloux, A. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02759.x · Cited by 176
Pseudomonas aeruginosa Elastase Degrades Surfactant Proteins A and D
Mariencheck, W. I., Alcorn, J. F., Palmer, S. M., & Wright, J. R. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0141oc · Cited by 173
Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis
GOMEZ, M., & PRINCE, A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.12.005 · Cited by 172
Newman, J. W., Floyd, R. V., & Fothergill, J. L. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx124 · Cited by 172
Sampedro, I., Parales, R. E., Krell, T., & Hill, J. E. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12081 · Cited by 172
Talà, L., Fineberg, A., Kukura, P., & Persat, A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0378-9 · Cited by 169
Type 3 secretion system of Pseudomonas aeruginosa
Horna, G., & Ruiz, J. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126719 · Cited by 167
Considerations and caveats in anti-virulence drug development
Maura, D., Ballok, A. E., & Rahme, L. G. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.06.001 · Cited by 159
Malloy, J. L., Veldhuizen, R. A. W., Thibodeaux, B. A., O’Callaghan, R. J., & Wright, J. R. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00322.2004 · Cited by 156
Microevolution of Pseudomonas aeruginosa to a Chronic Pathogen of the Cystic Fibrosis Lung
Hogardt, M., & Heesemann, J. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_199 · Cited by 154
Rollet, C., Gal, L., & Guzzo, J. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01415.x · Cited by 151
Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines
Campodónico, V. L., Llosa, N. J., Grout, M., Döring, G., Maira‐Litrán, T., & Pier, G. B. (2009) · Infection and Immunity · doi:10.1128/iai.00806-09 · Cited by 151
Pseudomonas aeruginosa Hemolytic Phospholipase C Suppresses Neutrophil Respiratory Burst Activity
Terada, L. S., Johansen, K. A., Nowbar, S., Vasil, A. I., & Vasil, M. L. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2371-2376.1999 · Cited by 150
Choy, M. H., Stapleton, F. J., Willcox, M. D. P., & Zhu, H. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.2008/003723-0 · Cited by 148
The Structure and Function of Type III Secretion Systems
Notti, R. Q., & Stebbins, C. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0004-2015 · Cited by 145
Elastase and the LasA Protease of Pseudomonas aeruginosa Are Secreted with Their Propeptides
Kessler, E., Safrin, M., Gustin, J. K., & Ohman, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30225 · Cited by 139
Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa
Tielen, P., Rosenau, F., Wilhelm, S., Jaeger, K., Flemming, H., & Wingender, J. (2010) · Microbiology · doi:10.1099/mic.0.037036-0 · Cited by 136
Bonneau, A., Roche, B., & Schalk, I. J. (2020) · Scientific Reports · doi:10.1038/s41598-019-56913-x · Cited by 136
Casilag, F., Lorenz, A., Krueger, J., Klawonn, F., Weiß, S., & Häußler, S. (2015) · Infection and Immunity · doi:10.1128/iai.00939-15 · Cited by 133
Rezzoagli, C., Archetti, M., Mignot, I., Baumgartner, M., & Kümmerli, R. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000805 · Cited by 126
Kollberg, H., Carlander, D., Olesen, H. V., Wejåker, P., Johannesson, M., & Larsson, A. (2003) · Pediatric Pulmonology · doi:10.1002/ppul.10290 · Cited by 125
Ali, S. O., Yu, X. Q., Robbie, G. J., Wu, Y., Shoemaker, K., Yu, L., DiGiandomenico, A., Keller, A. E., Anude, C., Hernandez-Illas, M., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.08.004 · Cited by 124
Elsen, S., Huber, P., Bouillot, S., Couté, Y., Fournier, P., Dubois, Y., Timsit, J., Maurin, M., & Attrée, I. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.01.003 · Cited by 121
Tielen, P., Kuhn, H., Rosenau, F., Jaeger, K., Flemming, H., & Wingender, J. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-159 · Cited by 120
Inhibitors and Specificity of Pseudomonas aeruginosa LasA
Kessler, E., Safrin, M., Abrams, W. R., Rosenbloom, J., & Ohman, D. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9884 · Cited by 119
Salacha, R., Kovačić, F., Brochier‐Armanet, C., Wilhelm, S., Tommassen, J., Filloux, A., Voulhoux, R., & Bleves, S. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02174.x · Cited by 119
D’Angelo, F., Baldelli, V., Halliday, N., Pantalone, P., Polticelli, F., Fiscarelli, E. V., Williams, P. M., Visca, P., Leoni, L., & Rampioni, G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01296-18 · Cited by 118
Impairment of Apoptotic Cell Engulfment by Pyocyanin, a Toxic Metabolite of Pseudomonas aeruginosa
Bianchi, S. M., Prince, L. R., McPhillips, K. A., Allen, L., Marriott, H. M., Taylor, G. W., Hellewell, P. G., Sabroe, I., Dockrell, D. H., Henson, P. W., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200612-1804oc · Cited by 115
Jain, R., Beckett, V. V., Konstan, M. W., Accurso, F. J., Burns, J. L., Mayer-Hamblett, N., Milla, C. E., VanDevanter, D. R., & Chmiel, J. F. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.12.006 · Cited by 115
Incidence of Pseudomonas aeruginosa Bacteremia: A Population-Based Study
Al‐Hasan, M. N., Wilson, J. W., Lahr, B. D., Eckel‐Passow, J. E., & Baddour, L. M. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.03.029 · Cited by 102
Quorum Quenching: A Potential Target for Antipseudomonal Therapy
Hemmati, F., Salehi, R., Ghotaslou, R., Kafil, H. S., Hasani, A., Gholizadeh, P., Nouri, R., & Rezaee, M. A. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s263196 · Cited by 101
Jyot, J., Balloy, V., Jouvion, G., Verma, A., Touqui, L., Huerre, M., Chignard, M., & Ramphal, R. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir045 · Cited by 99
Origin and impact of nitric oxide in Pseudomonas aeruginosa biofilms
Cutruzzolà, F., & Frankenberg-Dinkel, N. (2016) · Journal of Bacteriology · doi:10.1128/jb.00371-15 · Cited by 98
Horna, G., Amaro, C., Palacios, A., Guerra, H., & Ruiz, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-47303-4 · Cited by 92
Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosa
Agnello, M., & Wong‐Beringer, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042973 · Cited by 86
Pseudomonas aeruginosa lipopolysaccharides and pathogenesis
Goldberg, J. B., & Pier, G. B. (1996) · Trends in Microbiology · doi:10.1016/s0966-842x(97)82911-3 · Cited by 83
Song, Z., Wu, H. W., Ciofu, O., et al. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05122-0 · Cited by 78
Novel Pyoverdine Inhibitors Mitigate Pseudomonas aeruginosa Pathogenesis
Kirienko, D. R., Kang, D., & Kirienko, N. V. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03317 · Cited by 76
OligoG CF-5/20 Disruption of Mucoid Pseudomonas aeruginosa Biofilm in a Murine Lung Infection Model
Hengzhuang, W., Song, Z., Ciofu, O., Onsøyen, E., Rye, P. D., & Høiby, N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01721-15 · Cited by 75
Galdino, A. C. M., Viganor, L., de Castro, A. A., da Cunha, E. F. F., de Mello, T. P., Mattos, L. M. M., Pereira, M. D., Hunt, M. C., O’Shaughnessy, M., Howe, O. L., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01701 · Cited by 73
Pseudomonas aeruginosa Pore-Forming Exolysin and Type IV Pili Cooperate To Induce Host Cell Lysis
Basso, P., Ragno, M., Elsen, S., Reboud, E., Golovkine, G. R., Bouillot, S., Huber, P., Lory, S. J., Faudry, É., & Attrée, I. (2017) · mBio · doi:10.1128/mbio.02250-16 · Cited by 72
Pseudomonas aeruginosa Keratitis: Protease IV and PASP as Corneal Virulence Mediators
O’Callaghan, R. J., Caballero, A. R., Tang, A., & Bierdeman, M. A. (2019) · Microorganisms · doi:10.3390/microorganisms7090281 · Cited by 69
Lipase LipC affects motility, biofilm formation and rhamnolipid production in Pseudomonas aeruginosa
Rosenau, F., Isenhardt, S., Gdynia, A., Tielker, D., Schmidt, E., Tielen, P., Schobert, M., Jahn, D., Wilhelm, S., & Jaeger, K. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02017.x · Cited by 68
Quorum sensing inhibition inPseudomonas aeruginosabiofilms: new insights through network mining
Pérez‐Pérez, M., Jorge, P., Rodríguez, G. P., Pereira, M. O., & Lourenço, A. M. G. (2017) · Biofouling · doi:10.1080/08927014.2016.1272104 · Cited by 67
Webster, S. S., Lee, C. K., Schmidt, W. C., Wong, G. C. L., & O’Toole, G. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105566118 · Cited by 64
An inside look at a biofilm: Pseudomonas aeruginosa flagella biotracking
Ozer, E., Yaniv, K., Chetrit, E., Boyarski, A., Meijler, M. M., Berkovich, R., Kushmaro, A., & Alfonta, L. (2021) · Science Advances · doi:10.1126/sciadv.abg8581 · Cited by 63
Sun, Z., Kang, Y., Norris, M. H., Troyer, R. M., Son, M. S., Schweizer, H. P., DOW, S. W., & Hoang, T. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103778 · Cited by 60
Neville, N., Roberge, N. A., Ji, X. L., Stephen, P., Lu, J., & Jia, Z. (2021) · mBio · doi:10.1128/mbio.00592-21 · Cited by 60
Dar, H. H., Epperly, M. W., Tyurin, V. A., Amoscato, A. A., Anthonymuthu, T. S., Souryavong, A. B., Kapralov, A. A., Shurin, G. V., Самович, С. Н., Croix, C. M. S., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.156013 · Cited by 54
Sécher, T., Fauconnier, L., Szade, A., Rutschi, O., Fas, S. C., Ryffel, B., & Rudolf, M. P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr038 · Cited by 53
Lazar, H., Horn, M. P., Zuercher, A. W., Imboden, M. A., Durrer, P., Seiberling, M., Pokorny, R., Hammer, C., & Lang, A. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01699-08 · Cited by 52
Daddaoua, A., Molina‐Santiago, C., de la Torre, J., Krell, T., & Ramos, J. L. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku496 · Cited by 51
O’Donnell, J. N., Bidell, M. R., & Lodise, T. P. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2449 · Cited by 48
Nilsson, E., Amini, A., Wretlind, B., & Larsson, A. O. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.05.029 · Cited by 43
Kany, A. M., Sikandar, A., Haupenthal, J., Yahiaoui, S., Maurer, C. K., Proschak, E., Koehnke, J., & Hartmann, R. W. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00010 · Cited by 43
Matsumoto, T., Tateda, K., Furuya, N., Miyazaki, S., Ohno, A., Ishii, Y., Hirakata, Y., & Yamaguchi, K. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-4-303 · Cited by 41
Agnello, M., Finkel, S. E., & Wong‐Beringer, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01591 · Cited by 41
Scharmann, W. (1976) · Infection and Immunity · doi:10.1128/iai.13.3.836-843.1976 · Cited by 39
Morello, E., Pérez, T., Boisseau, C., Baranek, T., Guillon, A., Bréa, D., Lanotte, P., Carpena, X., Pietrancosta, N., Hervé, V., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01826 · Cited by 39
Cunrath, O., Graulier, G., Lopez, A. Y. C., Pérard, J., Forster, A., Geoffroy, V. A., Auguste, P. S., Bumann, D., Mislin, G. L. A., Michaud‐Soret, I., et al. (2020) · Metallomics · doi:10.1039/d0mt00029a · Cited by 36
Aldrovandi, M., Banthiya, S., Meckelmann, S. W., Zhou, Y., Heydeck, D., O’Donnell, V. B., & Kühn, H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.11.005 · Cited by 33
Kalms, J., Banthiya, S., Yoga, E. G., Hámberg, M., Holzhütter, H., Kühn, H., & Scheerer, P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.01.003 · Cited by 32
How to kill Pseudomonas —emerging therapies for a challenging pathogen
Yaeger, L. N., Coles, V. E., Chan, D. C. K., & Burrows, L. L. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14596 · Cited by 32
König, B., Vasil, M. L., & König, W. (1997) · Journal of Medical Microbiology · doi:10.1099/00222615-46-6-471 · Cited by 31
Pseudomonas aeruginosa Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease
Bradshaw, J. L., Caballero, A. R., Bierdeman, M. A., Adams, K. V., Pipkins, H. R., Tang, A., O’Callaghan, R. J., & McDaniel, L. S. (2018) · mSphere · doi:10.1128/msphere.00212-18 · Cited by 31
Anantharajah, A., Faure, E., Buyck, J. M., Sundin, C., Lindmark, T., Mecsas, J. C., Yahr, T. L., Tulkens, P. M., Mingeot‐Leclercq, M., Guery, B. P., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw295 · Cited by 30
Lu, J., Zhang, C., Leong, H. Y., Show, P. L., Lu, F., & Lu, Z. (2019) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2019.09.006 · Cited by 30
Inhibition of Pseudomonas aeruginosa Alginate Synthesis by Ebselen Oxide and Its Analogues
Kim, S.-K., Ngo, H., Dennis, E. K., Chandrika, N. T., DeShong, P. R., Garneau‐Tsodikova, S., & Lee, V. T. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00045 · Cited by 24
Bacterial phospholipases C with dual activity: phosphatidylcholinesterase and sphingomyelinase
Monturiol‐Gross, L., Villalta-Romero, F., Flores-Dı́az, M., & Alape‐Girón, A. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13320 · Cited by 24
Proctor, L. L., Ward, W. L., Roggy, C. S., Koontz, A. G., Clark, K. M., Quinn, A. P., Schroeder, M., Brooks, A. E., Small, J. M., Towne, F., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10121530 · Cited by 22
Preparation of Pseudomonas aeruginosa alginate-flagellin immunoconjugate
Faezi, S., Bahrmand, A. R., Mahdavi, M., Siadat, S. D., Sardari, S., Nikokar, I., Khanaki, K., Mirzajani, E., & Goudarzi, G. (2017) · Biologicals · doi:10.1016/j.biologicals.2017.04.001 · Cited by 20
Pan, S.-Y., Shih, Y., Huang, H.-H., Li, L.-H., Lin, Y.-T., & Yang, T. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.03.001 · Cited by 20
Zhang, A., Veesenmeyer, J. L., & Hauser, A. R. (2017) · Infection and Immunity · doi:10.1128/iai.00402-17 · Cited by 19
Bouillot, S., Pont, S., Gallet, B., Moriscot, C., Deruelle, V., Attrée, I., & Huber, P. (2020) · Cellular Microbiology · doi:10.1111/cmi.13251 · Cited by 18
Game of Trans-Kingdom Effectors
Bleves, S. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.08.002 · Cited by 17
Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa
Fraser-Pitt, D. J., Dolan, S. K., Toledo-Aparicio, D., Hunt, J. G., Smith, D. W., Lacy-Roberts, N., Hewage, P. S. N., Stoyanova, T. N., Manson, E. D. T., McLean, K., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.718213 · Cited by 17
Verma, N., Dollinger, P., Kovačić, F., Jaeger, K., & Gohlke, H. (2019) · Journal of Computational Chemistry · doi:10.1002/jcc.26085 · Cited by 16
Viegas, A., Dollinger, P., Verma, N., Kubiak, J., Viennet, T., Seidel, C. A. M., Gohlke, H., Etzkorn, M., Kovačić, F., & Jaeger, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-60093-4 · Cited by 16
Sass, G., Miller, L. C., Nguyen, T.-T. H., & Stevens, D. A. (2020) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trz136 · Cited by 15
Evolution of Subfamily I.1 Lipases in Pseudomonas aeruginosa
Zhang, Z., & Zhang, X. (2021) · Current Microbiology · doi:10.1007/s00284-021-02589-4 · Cited by 15
Cited by
Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility
Letizia, M., Diggle, S. P., & Whiteley, M. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01193-8 · Cited by 231
Biofilm and wound healing: from bench to bedside
Goswami, A. G., Basu, S., Banerjee, T., & Shukla, V. K. (2023) · European Journal of Medical Research · doi:10.1186/s40001-023-01121-7 · Cited by 178
Verdial, C., Serrano, I., Tavares, L., Gil, S., & Oliveira, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041221 · Cited by 71
Metadata
- Authors
- Liao, C., Huang, X., Wang, Q., Yao, D., & Lu, W.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-07-06
- Volume
- 12
- Pages
- 926758-926758
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W4286633111
- Cited by
- 309
- References
- 155
- FWCI
- 15.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.